ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • alcohol use
  • Alcohol use and gout
  • alcohol use and pain
  • Alignment
  • Alignment and osteoarthritis
  • Allopurinol
  • Allopurinol and gout
  • Allopurinol and uric acid
  • Alternative Activation
  • alternative medicine
  • Amyloidosis
  • Amyloidosis and ankylosing spondylitis (AS)
  • amyloidosis and familial Mediterranean fever
  • Amyloidosis and positron emission tomography (PET)
  • Amyopathic dermatomyositis
  • amyopathic dermatomyositis and interstitial lung disease
  • ANA
  • ANA and antibodies
  • ANA and Diagnostic Tests
  • ANA and education
  • ANA and environmental factors
  • ANA and health care cost
  • ANA and laboratory tests
  • ANA and quality improvement
  • ANA and rheumatic disease
  • ANA and SLE
  • ANA and systemic illness
  • ANA and systemic lupus erythematosus (SLE)
  • Anakinra
  • anakinra and bone disease
  • Anakinra and cardiovascular disease
  • anakinra and familial Mediterranean fever
  • anakinra and fever
  • Anakinra and gout
  • anakinra and histopathologic
  • anakinra and interleukins (IL)
  • anakinra and treatment
  • analgesics
  • Anatomy
  • Anatomy and education
  • Anatomy and educational innovation
  • ANCA
  • ANCA and body mass
  • ANCA and cardiovascular disease
  • ANCA and Churg-Strauss syndrome
  • ANCA and Elderly
  • ANCA and systemic lupus erythematosus (SLE)
  • ANCA and systemic sclerosis
  • ANCA and vasculitis
  • ANCA and Wegener's granulomatosis
  • and SLE
  • Anemia
  • Anemia and gout
  • anemia and systemic lupus erythematosus (SLE)
  • angiitis
  • angioedema and pediatric rheumatology
  • Angiogenesis
  • angiogenesis and autoimmune diseases
  • Angiogenesis and endothelial cells
  • Angiogenesis and inflammatory arthritis
  • angiogenesis and metabolism
  • angiogenesis and pregnancy
  • angiogenesis and psoriasis
  • Angiogenesis and rheumatoid arthritis
  • Angiogenesis and rheumatoid arthritis (RA)
  • Angiogenesis and signal transduction
  • Angiogenesis and systemic sclerosis
  • Angiography
  • angiopoietin
  • angiopoietin and inflammatory arthritis
  • angiopoietin and vasculitis
  • Angiotensin
  • Angiotensin and rheumatoid arthritis
  • Animal models
  • animal models and apoptosis
  • Animal models and arthritis
  • animal models and autoimmune diseases
  • animal models and catecholamines
  • animal models and glomerulonephritis
  • Animal models and inflammation
  • animal models and inflammatory arthritis
  • animal models and lupus nephritis
  • Animal models and lymph node
  • Animal models and matrix metalloproteinase (MMP)
  • Animal models and metabolic syndrome
  • Animal models and mycophenolate mofetil
  • animal models and non-human primates (NHPs)
  • Animal models and osteoarthritis
  • Animal models and osteoclastogenesis
  • animal models and pain
  • animal models and rheumatoid arthritis
  • animal models and rheumatoid arthritis (RA)
  • animal models and risk
  • Animal models and scleroderma
  • animal models and severity
  • animal models and signal transduction
  • animal models and small molecules
  • animal models and spondylarthritis
  • animal models and stem cells
  • animal models and steroids
  • animal models and synovial cells
  • animal models and synovium
  • animal models and systemic lupus erythematosus (SLE)
  • Animal models and systemic sclerosis
  • animal models and therapeutic targeting
  • animal models and therapy
  • animal models and tofacitinib
  • animal models and tolerance
  • animal models and toll-like receptors
  • animal models and transcription factor
  • animal models and transcriptional regulation
  • animal models and treatment
  • animal models and tumor necrosis factor (TNF)
  • animal models and type II collagen
  • animal models and ultrasound
  • animal models and vaccines
  • animal models and viruses
  • Ankle
  • ankle and rheumatoid arthritis (RA)
  • Ankylosing spondylitis (AS)
  • Ankylosing spondylitis (AS) and anti-TNF therapy
  • ankylosing spondylitis (AS) and axial spondyloarthritis
  • Ankylosing spondylitis (AS) and biomarkers
  • ankylosing spondylitis (AS) and biosimilars
  • ankylosing spondylitis (AS) and bone density
  • Ankylosing spondylitis (AS) and cardiovascular disease
  • ankylosing spondylitis (AS) and cartilage
  • Ankylosing spondylitis (AS) and chronic disease care
  • Ankylosing spondylitis (AS) and clinical practice
  • ankylosing spondylitis (AS) and clinical trials
  • ankylosing spondylitis (AS) and comparative effectiveness and harms
  • Ankylosing spondylitis (AS) and computed tomography (CT)
  • ankylosing spondylitis (AS) and death
  • Ankylosing spondylitis (AS) and dendritic cells
  • ankylosing spondylitis (AS) and diagnosis
  • ankylosing spondylitis (AS) and enthesis
  • Ankylosing spondylitis (AS) and epidemiologic methods
  • Ankylosing spondylitis (AS) and epigenetics
  • Ankylosing spondylitis (AS) and exercise
  • Ankylosing spondylitis (AS) and extraarticular manifestations
  • Ankylosing spondylitis (AS) and familial Mediterranean fever
  • ankylosing spondylitis (AS) and fibromyalgia
  • Ankylosing spondylitis (AS) and functional status
  • Ankylosing spondylitis (AS) and genetic disorders
  • Ankylosing spondylitis (AS) and genetics
  • Ankylosing spondylitis (AS) and genomics
  • Ankylosing spondylitis (AS) and glucocorticoids
  • Ankylosing spondylitis (AS) and guidelines
  • Ankylosing spondylitis (AS) and hip disorders
  • ankylosing spondylitis (AS) and human leukocyte antigens (HLA)
  • Ankylosing spondylitis (AS) and infection
  • ankylosing spondylitis (AS) and inflammation
  • ankylosing spondylitis (AS) and inflammatory arthritis
  • Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD)
  • Ankylosing spondylitis (AS) and infliximab
  • ankylosing spondylitis (AS) and laboratory tests
  • ankylosing spondylitis (AS) and longitudinal studies
  • Ankylosing spondylitis (AS) and macrophage migration inhibitory factor (MIF)
  • Ankylosing spondylitis (AS) and magnetic resonance imaging (MRI)
  • Ankylosing spondylitis (AS) and major histocompatibility complex (MHC)
  • ankylosing spondylitis (AS) and medication
  • ankylosing spondylitis (AS) and mHealth
  • Ankylosing spondylitis (AS) and microbiome
  • Ankylosing spondylitis (AS) and monoclonal antibodies
  • ankylosing spondylitis (AS) and mucosal T cells
  • Ankylosing spondylitis (AS) and nonsteroidal antiinflammatory drugs (NSAIDs)
  • Ankylosing spondylitis (AS) and osteoporosis
  • Ankylosing spondylitis (AS) and outcome measures
  • ankylosing spondylitis (AS) and patient questionnaires
  • ankylosing spondylitis (AS) and physical activity
  • Ankylosing spondylitis (AS) and polymorphism
  • ankylosing spondylitis (AS) and posture
  • ankylosing spondylitis (AS) and prognostic factors
  • Ankylosing spondylitis (AS) and proteomics
  • ankylosing spondylitis (AS) and psoriatic arthritis
  • Ankylosing spondylitis (AS) and quality of care
  • Ankylosing spondylitis (AS) and quality of life
  • Ankylosing spondylitis (AS) and radiography
  • Ankylosing spondylitis (AS) and range of motion
  • ankylosing spondylitis (AS) and registries
  • ankylosing spondylitis (AS) and registry
  • ankylosing spondylitis (AS) and regulatory cells
  • Ankylosing spondylitis (AS) and rheumatoid arthritis (RA)
  • Ankylosing spondylitis (AS) and sarcopenia
  • Ankylosing spondylitis (AS) and self-management
  • ankylosing spondylitis (AS) and sleep disorders
  • ankylosing spondylitis (AS) and socioeconomic status
  • ankylosing spondylitis (AS) and spine involvement
  • Ankylosing spondylitis (AS) and spondylarthritis
  • Ankylosing spondylitis (AS) and spondylarthropathy
  • Ankylosing spondylitis (AS) and thrombosis
  • ankylosing spondylitis (AS) and treatment
  • Ankylosing spondylitis (AS) and tumor necrosis factor (TNF)
  • ankylosing spondylitis (AS) and ultrasound
  • Ankylosing spondylitis (AS) and uveitis
  • ankylosing spondylitis (AS) and well-being
  • Ankylosing spondylitis (AS) and work
  • Annexins
  • Anti TNF
  • anti-beta2 Glycoprotein I antibodies
  • « Previous Page
  • 1
  • [2]
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Chicago, IL

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.